| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/13/2023 | — | Piper Sandler | Upgrades | Neutral → Overweight | |
| 07/27/2023 | 21.22% | Keefe, Bruyette & Woods | $72 → $75 | Maintains | Market Perform |
| 07/27/2023 | 32.54% | Raymond James | $77 → $82 | Maintains | Outperform |
| 04/27/2023 | 29.3% | Wells Fargo | $85 → $80 | Maintains | Equal-Weight |
| 04/27/2023 | 24.45% | Raymond James | $73 → $77 | Maintains | Outperform |
| 04/06/2023 | 17.99% | Raymond James | $104 → $73 | Maintains | Outperform |
| 04/06/2023 | 19.61% | Keefe, Bruyette & Woods | $90 → $74 | Maintains | Market Perform |
| 04/05/2023 | 37.38% | Wells Fargo | $95 → $85 | Maintains | Equal-Weight |
| 01/27/2023 | 68.09% | Raymond James | $101 → $104 | Maintains | Outperform |
| 01/26/2023 | 43.85% | Piper Sandler | $86 → $89 | Maintains | Neutral |
| 01/26/2023 | 53.55% | Wells Fargo | $90 → $95 | Maintains | Equal-Weight |
| 01/26/2023 | 51.93% | Janney Montgomery Scott | → $94 | Downgrades | Buy → Neutral |
| 10/27/2022 | 45.47% | Wells Fargo | $95 → $90 | Maintains | Equal-Weight |
| 10/27/2022 | 63.25% | Raymond James | $110 → $101 | Maintains | Outperform |
| 07/28/2022 | 77.79% | Raymond James | $108 → $110 | Maintains | Outperform |
| 07/07/2022 | 74.56% | Raymond James | $113 → $108 | Maintains | Outperform |
| 04/28/2022 | 61.63% | Wells Fargo | $110 → $100 | Maintains | Equal-Weight |
| 04/28/2022 | 82.64% | Raymond James | $120 → $113 | Maintains | Outperform |
| 03/18/2022 | 93.96% | Raymond James | $110 → $120 | Maintains | Outperform |
| 01/04/2022 | — | Wells Fargo | Downgrades | Overweight → Equal-Weight | |
| 12/21/2021 | 85.87% | Janney Montgomery Scott | → $115 | Upgrades | Neutral → Buy |
| 10/07/2021 | 85.87% | Wells Fargo | $110 → $115 | Maintains | Overweight |
| 04/29/2021 | 77.79% | Wells Fargo | $105 → $110 | Maintains | Overweight |
| 04/29/2021 | 77.79% | Raymond James | $82 → $110 | Maintains | Outperform |
| 01/28/2021 | 32.54% | Raymond James | $69 → $82 | Maintains | Outperform |
| 09/29/2020 | -22.42% | Piper Sandler | $51 → $48 | Maintains | Neutral |
| 08/20/2020 | 6.68% | Raymond James | $65 → $66 | Maintains | Outperform |
| 01/06/2020 | -3.02% | Wells Fargo | → $60 | Downgrades | Equal-Weight → Underweight |
| 03/15/2019 | 14.76% | Raymond James | $70 → $71 | Maintains | Outperform |
| 01/31/2019 | 13.14% | Raymond James | → $70 | Upgrades | Market Perform → Outperform |
| 01/10/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 10/25/2018 | 11.52% | Raymond James | $81 → $69 | Maintains | Outperform |
What is the target price for UMB Financial (UMBF)?
The latest price target for UMB Financial (NASDAQ: UMBF) was reported by Piper Sandler on September 13, 2023. The analyst firm set a price target for $0.00 expecting UMBF to fall to within 12 months (a possible -100.00% downside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for UMB Financial (UMBF)?
The latest analyst rating for UMB Financial (NASDAQ: UMBF) was provided by Piper Sandler, and UMB Financial upgraded their overweight rating.
When is the next analyst rating going to be posted or updated for UMB Financial (UMBF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of UMB Financial, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for UMB Financial was filed on September 13, 2023 so you should expect the next rating to be made available sometime around September 13, 2024.
Is the Analyst Rating UMB Financial (UMBF) correct?
While ratings are subjective and will change, the latest UMB Financial (UMBF) rating was a upgraded with a price target of $0.00 to $0.00. The current price UMB Financial (UMBF) is trading at is $61.87, which is out of the analyst's predicted range.